BACKGROUND Here we describe the consensus guideline methodology, summarise the
evidence-based recommendations we provided to the World Health Organisation (WHO) for …

Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

Polycystic ovary syndrome (PCOS) represents the most common endocrine dysfunction in
fertile women and it is considered a heterogeneous and multifaceted disorder, with multiple …

Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2
diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin …

Background Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder
characterized by anovulation, hyperandrogenism, and polycystic ovarian morphology. The …

BACKGROUND Polycystic ovary syndrome (PCOS) is associated with poor quality of life
(QoL) and high levels of depression. Existing research is confounded by small sample sizes …

Objective Polycystic ovary syndrome (PCOS) has been shown to cause a reduction in
quality of life. This study examines the extent of different PCOS symptoms on quality-of-life …

Introduction Polycystic ovary syndrome (PCOS) is associated with biochemical and
hormonal disturbance and adverse cosmetic, reproductive, metabolic, and psychological …

BACKGROUND This study examined the relationship between emotional distress as
measured by the Hospital Anxiety and Depression Scale (HADS) and the Fertility Quality of …

BACKGROUND For a number of reasons, the results of previous meta-analyses may not
fully reflect the mental health status of the average woman suffering from polycystic ovary …